InvestorsHub Logo
Followers 2
Posts 48
Boards Moderated 0
Alias Born 10/22/2013

Re: glass99 post# 203

Tuesday, 12/01/2015 4:18:53 PM

Tuesday, December 01, 2015 4:18:53 PM

Post# of 260
I meant to say...

Finally, one "dark horse" bidder not mentioned in the article is Ladenburg Thalmann Financial Services Inc. (LTS). While there are potential issues, they are in need of an acquisition in order to continue their top line growth.

I pressed Submit Post before I had read through the entire post.

Two more points:

First:

In my April 18, 2015 post (#173) I said, "The risk is someone will attempt to takeover NHLD before the company has adequate visibility to new shareholders. As a result, the acquiring company may attempt to offer NHLD shareholders a price that is below fair value."

CB Pharma has turned this risk into a reality.

In the post, I also discussed the factors that may have dissuaded a below fair value offer. Well, now these factors can be utilized to prevent a coerced takeover, if necessary.

See the factors here (post #173):

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112872010


Second:

As noted in my October 7, 2015 post (#191), NHLD's Chairman and CEO, Fagenson, is now effectively on a month-to-month contract, and NHLD's President, Mark Goldwasser, will be on a month-to-month contract beginning on February 1, 2016 (a month before his term ends).

See the 8-K here (post #191):

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117552720